The Verhaak Lab
Brain tumors, sequencing, computational biology.
Brain tumors, sequencing, computational biology.
We are a computational cancer biology lab with a research focus on the analysis of cancer genomics data to improve our understanding of cancer biology. We have a specialized research interest in understanding disease progression of brain tumors, particularly glioblastoma and glioma. We mostly use high throughput sequencing and computational analysis in our research.
Dr. Jens Rueter and the Maine Cancer Genomics Initiative are providing advanced genomic tools to oncology practices...
Doctors who treat rare pediatric cancers face an awful truth: many of their patients will die far too young.
Deploys next-generation sequencing techniques to understand brain tumor biology and telomere mechanics
Leverages genomic technologies to investigate brain tumor biology and disease evolution.
Computational analysis of high throughput sequencing data to improve our understanding of tumor biology and evolution.
Brain tumors, sequencing, computational biology.
Professor Roel Verhaak, Ph.D., is focused on the analysis of cancer genomics data to improve our understanding of cancer...
Working in the comparative oncology field to study spontaneous development of glioma in Canis familiaris or dogs with emphasis on...
This course prepares participants for team science aimed specifically toward interrogation of the systems genetics of...
A team including JAX Professor Roel Verhaak, Ph.D., investigated genes implicated in self-renewal and therapy resistance in glioblastoma...
Postdoctoral Associate Eunhee Yi has been awarded a $100,000 fellowship from the American Brain Tumor Association to discover how...
New research is providing a better understanding of the processes underlying cell-to-cell differences within glioblastoma tumors — a...
Professor Roel Verhaak is analyzing genomic data sets from human and canine brain tumors to solve the mystery of why cancer...
Because March is Colorectal Cancer Awareness Month, we wanted to circle back around to the screening guideline released by...
Communicating about the goals of genomic tumor testing and the associated benefits and limitations with patients like Carole will guide...
Genetic testing is becoming increasingly accessible for patients as the list of clinical indications and number of genes are growing, and...